In a study of the cost of TB in India, a direct cost of Rs. 29.68 crores annually has been estimated. The morbidity and mortality losses have been quantified taking into account the urban and rural population separately. The data on mortality in rural areas is very meager and is not available according to age and sex. This, and the expected working life for premature mortality have been calculated by the application of statistical methods. The morbidity loss has been estimated at Rs. 288.4 crores and the mortality losses at Rs. 420.41 crores at 4 percent deduction and Rs. 304.96 crores at 10 percent deduction.